Skip to content

Rapport Therapeutics, Inc. RAPP Return on invested capital

Return on invested capital at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
13%+4.2pp
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
-6.4%-11.8pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-59.1%+48.1pp
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
-62.2%-21.5pp
Biohaven logo
BiohavenBHVN
-395.4%-85.9pp
Septerna, Inc. logo
Septerna, Inc.SEPN
-27.8%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$24.2M+10.7%
Net income-$19.9M+17.5%
EPS (diluted)-$0.42+38.2%

Balance sheet

See full
Cash & equivalents$78.1M+35.5%
Total debt$10.8M+37.8%
Total equity$471.5M+65.0%
Total assets$497.6M+64.7%

Cash flow

See full
Operating cash flow-$13.1M+35.5%
CapEx$86.0K-70.4%
Free cash flow-$13.1M+36.0%

Valuation

See full
Market cap$1.86B+309%
Enterprise value$1.79B+352%

Returns & leverage

See full
Return on equity-28.3%
Debt / equity0.0×
Current ratio27.1×-3.9×

Where this comes from

Calculated from Rapport Therapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s return on invested capital?
Rapport Therapeutics, Inc. (RAPP) reported return on invested capital of -38.2% in Q1 2026.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.